Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flepp

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Archives of Internal Medicine|July 10, 1999
Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort StudyR Weber, B Ledergerber, R Zbinden, et al.
Lancet (London, England)|October 31, 2001
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort StudyJ Fellay, K Boubaker, B Ledergerber, et al.
The New England Journal of Medicine|April 29, 1999
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort StudyH Furrer, M Egger, M Opravil, et al.
Lancet (London, England)|March 27, 1999
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort StudyB Ledergerber, M Egger, M Opravil, et al.
AIDS (London, England)|July 9, 2004
The role of CFTR and SPINK-1 mutations in pancreatic disorders in HIV-positive patients: a case-control studyChristian Felley, Michael A Morris, Ambroise Wonkam, et al.
BMJ (Clinical Research Ed.)|January 3, 2004
Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort studyJim Young, Sabina De Geest, Rebecca Spirig, et al.
Heart (British Cardiac Society)|March 31, 2005
Effects of statins on endothelial function and lipid profile in HIV infected persons receiving protease inhibitor-containing anti-retroviral combination therapy: a randomised double blind crossover trialD Hürlimann, R Chenevard, F Ruschitzka, et al.
AIDS (London, England)|March 9, 2000
Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort StudyP L Vernazza, L Troiani, M J Flepp, et al.
HIV Medicine|September 25, 2012
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort StudyR Weber, M Ruppik, M Rickenbach, et al.
Antiviral Therapy|December 3, 2003
Impact of genotypic resistance testing on selection of salvage regimen in clinical practiceStefan Haupts, Bruno Ledergerber, Jörg Böni, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Archives of Internal Medicine|July 10, 1999
Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort StudyR Weber, B Ledergerber, R Zbinden, et al.
Lancet (London, England)|October 31, 2001
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort StudyJ Fellay, K Boubaker, B Ledergerber, et al.
The New England Journal of Medicine|April 29, 1999
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort StudyH Furrer, M Egger, M Opravil, et al.
Lancet (London, England)|March 27, 1999
Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort StudyB Ledergerber, M Egger, M Opravil, et al.
AIDS (London, England)|July 9, 2004
The role of CFTR and SPINK-1 mutations in pancreatic disorders in HIV-positive patients: a case-control studyChristian Felley, Michael A Morris, Ambroise Wonkam, et al.
BMJ (Clinical Research Ed.)|January 3, 2004
Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort studyJim Young, Sabina De Geest, Rebecca Spirig, et al.
Heart (British Cardiac Society)|March 31, 2005
Effects of statins on endothelial function and lipid profile in HIV infected persons receiving protease inhibitor-containing anti-retroviral combination therapy: a randomised double blind crossover trialD Hürlimann, R Chenevard, F Ruschitzka, et al.
AIDS (London, England)|March 9, 2000
Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort StudyP L Vernazza, L Troiani, M J Flepp, et al.
HIV Medicine|September 25, 2012
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort StudyR Weber, M Ruppik, M Rickenbach, et al.
Antiviral Therapy|December 3, 2003
Impact of genotypic resistance testing on selection of salvage regimen in clinical practiceStefan Haupts, Bruno Ledergerber, Jörg Böni, et al.
Pageof 12